Idiopathic hypereosinophilic syndrome with eosinophilic cellulitis-like cutaneous involvement treated with mepolizumab and dapsone.

Lachance M, Bernard J, Lavoie A, Gagné É, Grenier PO

Open source

DOI
10.1016/j.jdcr.2022.01.022
Published
2022 Apr
Container
JAAD case reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jdcr.2022.01.022,
  title = {Idiopathic hypereosinophilic syndrome with eosinophilic cellulitis-like cutaneous involvement treated with mepolizumab and dapsone.},
  author = {Lachance M and Bernard J and Lavoie A and Gagné É and Grenier PO},
  year = {2022},
  journal = {JAAD case reports},
  doi = {10.1016/j.jdcr.2022.01.022},
  url = {https://doi.org/10.1016/j.jdcr.2022.01.022}
}

RIS

TY  - JOUR
TI  - Idiopathic hypereosinophilic syndrome with eosinophilic cellulitis-like cutaneous involvement treated with mepolizumab and dapsone.
AU  - Lachance M
AU  - Bernard J
AU  - Lavoie A
AU  - Gagné É
AU  - Grenier PO
PY  - 2022
JO  - JAAD case reports
DO  - 10.1016/j.jdcr.2022.01.022
UR  - https://doi.org/10.1016/j.jdcr.2022.01.022
ER  - 

APA

M, L., J, B., A, L., É, G., & PO, G. (2022). Idiopathic hypereosinophilic syndrome with eosinophilic cellulitis-like cutaneous involvement treated with mepolizumab and dapsone.. JAAD case reports. https://doi.org/10.1016/j.jdcr.2022.01.022

Source records